⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
Class Action Reminder from Pomerantz LLP for Shareholders of Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - RGRD Law
globenewswire.com
RARE
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
RARE
Pomerantz LLP Updates Shareholders on Legal Action Brought Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
RARE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Investors of Securities Class Action Deadline on April 6, 2026
prnewswire.com
RARE
RARE Shareholders Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
RARE
ULTRAGENYX DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RARE
accessnewswire.com
RARE
Class Action Reminder from Pomerantz LLP for Investors of Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
Pomerantz LLP Updates Investors on Legal Action Brought Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
prnewswire.com
RARE